Boryeong Mometasone Spray (Mometasone Furoate)

Adult use

1. Allergic rhinitis Adults (including elderly) and adolescents over 12 years: Generally, spray 2 sprays in each nostril once daily (total daily dose 0.2 mg). If symptoms are reduced, the maintenance dose can be decreased to 1 spray in each nostril (total daily dose 0.1 mg). If symptoms are not alleviated, the dose can be increased to a maximum of 4 sprays in each nostril once daily (total daily dose 0.4 mg).

Child use

Children aged 2 to 11 years: Generally, spray 1 spray in each nostril once daily (total daily dose 0.1 mg).

This medication should not be used in certain patients. For example, patients who are allergic to this medicine or its ingredients, have untreated infections of the nasal mucosa, have recently undergone nasal surgery, or have injuries in the nasal area, and infants under 2 years old should not use this drug. There are also precautions for patients who need careful use of this drug. Patients with active tuberculosis or untreated systemic infections, those with herpes simplex virus in the eyes, patients who experience recurrent nosebleeds, patients at risk of exposure to chickenpox or measles, those with certain nasal issues, women who are pregnant or may become pregnant, and nursing mothers should use this drug cautiously. Various side effects may occur when using this drug. Commonly reported side effects include headaches, viral infections, pharyngitis, nosebleeds, coughing, and upper respiratory infections, and less commonly, allergic reactions such as bronchospasm and difficulty breathing may occur. Prolonged high-dose use may lead to systemic side effects, so caution is required. Long-term use of this drug can cause changes to the nasal mucosa, necessitating regular examinations, and if local fungal infections occur, discontinuation or treatment may be required. Additionally, there is a risk of infection with chickenpox or measles while using this medication, so vaccination status should be verified, and immediate consultation with healthcare professionals is essential if an infection occurs. When using this drug in children, it may affect their growth rate, so growth status should be monitored regularly. It is not used in infants under 2 years as safety has not been established. In elderly patients, physiological functions may be impaired, and their condition should be monitored closely. Exceeding the prescribed dosage can result in systemic corticosteroid side effects, so patients must adhere to the determined dosage and usage instructions. Before use, shake the container well, and if there has been a long period of non-use, perform a test spray to ensure even spraying. This medication is for intranasal use only and should be applied carefully to avoid direct spraying into the eyes or on the septum. Lastly, it should be stored out of reach of children, and the effects on driving or operating machinery are unknown.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, mouth/eye mucosal pain, shortness of breath or difficulty breathing, asthma attack, coughing with fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination.

Mild side effects

Headache, viral infection, pharyngitis, nosebleed/blood-stained mucus, cough, upper respiratory infection, menstrual disorder, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, indigestion, ear pain, cold symptoms, muscle pain, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), positive nasal fungal test, sore throat.

This drug is sensitive to air and moisture, so it should be stored in a tightly closed container. It should be kept in a cool place between 2 and 25 degrees Celsius.

Appearance

An opaque suspension that is white or nearly white, contained in a device that releases a fixed amount per spray.

Package unit

10 grams (80 sprays)/bottle, 18 grams (140 sprays)/bottle